Medical devices, healthcare technology and the business of care
510(k) clearance · K262094

E3D-C Interbody System

Evolution Spine · Decision date Jul 22, 2026

FDA DECISIONK262094

What did the FDA decide?

FDA records K262094 as a 510(k) premarket notification, with a decision dated Jul 22, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Jul 22, 2026

FDA source record

Regulatory record facts

Identifier
K262094
Regulatory pathway
510(k) premarket notification
Product code
OVE
Decision code
SESE
Decision date
Jul 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Intervertebral Fusion Device With Integrated Fixation, Cervical.

Product code
OVE
FDA device class
2

FDA decision timeline

  1. K262094 received

    Application receipt date recorded by FDA.

  2. K262094 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OVE

Product / regulatory recordCompanyPathwayDecision dateSource
ZSFab, Inc.510(k) clearanceOct 2, 2026FDA
Medyssey Co., Ltd.510(k) clearanceSep 29, 2026FDA
Elevation Spine510(k) clearanceSep 23, 2026FDA
Osseus Fusions Systems, LLC510(k) clearanceAug 21, 2026FDA
ZSFab, Inc.510(k) clearanceJul 31, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Evolution Spine

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Dallas, TX

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records